DUBAG Group is a privately owned company headquartered in Germany. Founded in 2009, it employs approximately 20 individuals. Functioning as venture capital and private equity principals, DUBAG Investment Advisory operates as a Munich-based GP team. The company focuses on the buyout of companies in turnaround and special situations within the mid-market segment, with a geographic focus on Western Europe.
On August 27, 2026, the LEO III Fund, managed by DUBAG Group, acquired JPT Peptide Technologies GmbH from BioNTech Diagnostics GmbH, with Noerr advising on the transaction. JPT, founded in 2004 as a spin-off from Jerini AG, provides peptide-based research and development solutions. Previously, on June 19, 2026, the LEO III Fund signed a purchase agreement for the acquisition of Holcim Technical Solutions and Products GmbH (HTSP) from Holcim. HTSP, based in Edingen-Neckarhausen, manufactures engineered elastomer solutions and high-performance rubber materials for sectors including aerospace, mechanical engineering, mobility, and medical technology. This followed the completion of Saint-Gobain's divestment of its high-temperature industrial insulation textile business HKO in Germany and its French subsidiary Deltec to a DUBAG Group-managed fund on June 1, 2026. HKO, a specialist manufacturer of technical textile components primarily for high-temperature insulation in automotive and industrial applications, generated approximately €45 million in sales in 2025 and employed around 220 people. Saint-Gobain described the divestment as a step in its ongoing portfolio optimization strategy.
Subscribe for full access to DUBAG Group's products in full detail
Subscribe for full access to DUBAG Group's revenue in full detail
Subscribe for full access to DUBAG Group's products in full detail 
